R-CHOP + GM-CSF for Previously Untreated LCL in Elderly

Completed · Phase 2

Conditions studied: Lymphoma, Large B-Cell, Diffuse

In brief

Patients will receive 6 to 8 cycles of R-CHOP (Rituximab, Cyclophosphamide, doxorubicin, vincristine, and prednisone), with GM-CSF.

Key facts

Study ID

NCT00582725

Run by

University of Wisconsin, Madison

People needed

38

Starts

2002-03-01

Expected to finish

2010-11-01

Last updated by the study team

2019-12-13

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed, CD20+ B cell diffuse large cell lymphoma, with measurable or evaluable disease
• Having no prior chemotherapy, immunotherapy or radiotherapy except for one cycle of CHOP or R-CHOP.

You may not qualify if…

• Pregnant
• Hepatitis B Surface Antigen positive
• Have known CNS disease or HIV infection
• Have NY Classification III or IV disease.

Where it is running

• University Of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.